GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scancell Holdings PLC (LSE:SCLP) » Definitions » Cyclically Adjusted PS Ratio

Scancell Holdings (LSE:SCLP) Cyclically Adjusted PS Ratio : 9.60 (As of Apr. 28, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Scancell Holdings Cyclically Adjusted PS Ratio?

As of today (2024-04-28), Scancell Holdings's current share price is £0.096. Scancell Holdings's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Apr23 was £0.01. Scancell Holdings's Cyclically Adjusted PS Ratio for today is 9.60.

The historical rank and industry rank for Scancell Holdings's Cyclically Adjusted PS Ratio or its related term are showing as below:

LSE:SCLP' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 9.25   Med: 11.15   Max: 16.74
Current: 16

During the past 13 years, Scancell Holdings's highest Cyclically Adjusted PS Ratio was 16.74. The lowest was 9.25. And the median was 11.15.

LSE:SCLP's Cyclically Adjusted PS Ratio is ranked worse than
79.6% of 505 companies
in the Biotechnology industry
Industry Median: 5.24 vs LSE:SCLP: 16.00

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Scancell Holdings's adjusted revenue per share data of for the fiscal year that ended in Apr23 was £0.006. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is £0.01 for the trailing ten years ended in Apr23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Scancell Holdings Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Scancell Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scancell Holdings Cyclically Adjusted PS Ratio Chart

Scancell Holdings Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 26.07

Scancell Holdings Semi-Annual Data
Apr14 Oct14 Apr15 Oct15 Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 26.07 -

Competitive Comparison of Scancell Holdings's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Scancell Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scancell Holdings's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scancell Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Scancell Holdings's Cyclically Adjusted PS Ratio falls into.



Scancell Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Scancell Holdings's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.096/0.01
=9.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scancell Holdings's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Apr23 is calculated as:

For example, Scancell Holdings's adjusted Revenue per Share data for the fiscal year that ended in Apr23 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Apr23 (Change)*Current CPI (Apr23)
=0.006/128.3000*128.3000
=0.006

Current CPI (Apr23) = 128.3000.

Scancell Holdings Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201404 0.000 99.600 0.000
201504 0.000 99.900 0.000
201604 0.000 100.600 0.000
201704 0.000 103.200 0.000
201804 0.000 105.500 0.000
201904 0.000 107.600 0.000
202004 0.000 108.600 0.000
202104 0.000 110.400 0.000
202204 0.000 119.000 0.000
202304 0.006 128.300 0.006

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Scancell Holdings  (LSE:SCLP) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Scancell Holdings Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Scancell Holdings's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Scancell Holdings (LSE:SCLP) Business Description

Traded in Other Exchanges
Address
Sanders Road, Unit 202, Bellhouse Building, Oxford Science Park, Oxford, GBR, OX4 4GD
Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.

Scancell Holdings (LSE:SCLP) Headlines

No Headlines